Engineered Nano-carrier systems for the oral targeted delivery of follicle stimulating Hormone: Development, characterization, and, assessment of in vitro and in vivo performance and targetability-Reference-Cited by-同舟云学术

Engineered Nano-carrier systems for the oral targeted delivery of follicle stimulating Hormone: Development, characterization, and, assessment of in vitro and in vivo performance and targetability

Published:2023-04 Issue: Volume:637 Page:122868
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Raut Sushil Yadaorao,Fu Kengyen,Taichun Huang,Gahane Avinash,Chaudhari Dasharath,Kushwah Varun^ORCID,Suresh Managuli Renuka,Hegde Aswathi R.,Jain Sanyog^ORCID,Kalthur Guruprasad,Bandu Joshi Manjunath,Chang Hsin-I.,Dai Niann-Tzyy,Mutalik Srinivas^ORCID

Funder

Nano Mission

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference68 articles.

1. A comparison of three Peyer’s patch “M-like” cell culture models: particle uptake, bacterial interaction, and epithelial histology;Ahmad;Eur. J. Pharm. Biopharm.,2017

2. Enhanced oral bioavailability of insulin-loaded solid lipid nanoparticles: pharmacokinetic bioavailability of insulin-loaded solid lipid nanoparticles in diabetic rats;Ansari;Drug Deliv.,2016

3. Correlation between anti-mullerian and follicle-stimulating hormone in female infertility;Bala;Int J Health Allied Sci.,2014

4. Mechanism of transport of saquinavir-loaded nanostructured lipid carriers across the intestinal barrier;Beloqui;J. Control. Release,2013

5. A human intestinal M-cell-like model for investigating particle, antigen and microorganism translocation;Beloqui;Nat. Protoc.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The utilization of nanotechnology in the female reproductive system and related disorders;Heliyon;2024-02

2. RGD-modified solid lipid nanoparticles improve oral doxorubicin absorption: In vitro and in vivo study;Journal of Drug Delivery Science and Technology;2024-01

3. RGD peptide in cancer targeting: Benefits, challenges, solutions, and possible integrin–RGD interactions;Cancer Medicine;2024-01